Dr. Indranil Nandi, PhD

Dr. Nandi is a seasoned pharmaceutical professional with nearly 25 years of experience, supporting and executing strategic operational initiatives to drive business growth. He possesses expertise in CMC, IP, portfolio and program management, specializing in regulatory filing, manufacturing, and product launches. Previously, he served as Chief Scientific Officer at Jubilant Radiopharma, VP of R&D at Impax Laboratories, and spent over a decade at Sandoz/Novartis. He holds a PhD from St. John’s University and an MBA from Rutgers.